Clinical application of a new method for the determination of aminoacylase in human serum

1975 ◽  
Vol 63 (3) ◽  
pp. 271-274 ◽  
Author(s):  
Klaus Lorentz ◽  
Barbara Flatter
1995 ◽  
Vol 316 (3) ◽  
pp. 387-389 ◽  
Author(s):  
Wei Zeng ◽  
Xiangjing Meng ◽  
Na Li ◽  
Shenyang Tong

1974 ◽  
Vol 52 (2) ◽  
pp. 187-196 ◽  
Author(s):  
Anders Grahnén ◽  
Ingvar Sjöholm ◽  
Magnus Michaëlsson

2006 ◽  
Vol 188 (1) ◽  
pp. 155-159 ◽  
Author(s):  
Meritxell Nus ◽  
Francisco J. Sánchez-Muniz ◽  
José M. Sánchez-Montero

1960 ◽  
Vol 23 ◽  
pp. 227-232 ◽  
Author(s):  
P WEST ◽  
G LYLES
Keyword(s):  

1977 ◽  
Vol 37 (02) ◽  
pp. 210-215 ◽  
Author(s):  
R Margalit ◽  
E Gidron ◽  
Y Shalitin

SummaryThe term “effective activator” of plasminogen is proposed, to denote the resultant of activator-antiactivator interaction, and a method for the determination of the level of these activators is described. By adding axcess plasminogen to the euglobulin fraction of plasma the influence of the level of endogenous plasminogen and of the antiplasmin is eliminated. It is shown that the level of fibrinogen has very little bearing on the results. An effective activator unit is defined as equal to 1 CTA unit of urokinase activity on a fibrinogen-plasminogen substrate.


1964 ◽  
Vol 12 (01) ◽  
pp. 119-125 ◽  
Author(s):  
Y Shamash ◽  
A Rimon

SummaryA new method for the assay of plasmin inhibitors in human plasma is described. The method consists of determination of the caseinolytic activity of a standard plasmin solution before and after incubation with the inhibitor, with lysine added to the mixture as a stabilizer of plasmin. Using this method, it was found that plasma contains enough inhibitors to inactivate 30 caseinolytic units of plasmin, or 10 times the normal amount of plasminogen in human plasma.


Sign in / Sign up

Export Citation Format

Share Document